Axogen (AXGN) Income from Non-Controlling Interests (2024)

Axogen's (AXGN) quarterly Income from Non-Controlling Interests came in at $90000.0 in Q3 2024.

Axogen (AXGN) Income from Non-Controlling Interests (2024) Analysis & Trends

Axogen's Income from Non-Controlling Interests history runs 1 years deep, the most recent figure standing at $90000.0 for Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 183.13 Bn 175.84 Bn 6.27 Bn -
2 Stryker 128.86 Bn 125.99 Bn 3.81 Bn -
3 Medtronic 108.95 Bn 99.73 Bn 6.41 Bn 16.00 Mn
4 Boston Scientific 68.42 Bn 66.97 Bn 3.61 Bn -2.00 Mn
5 Edwards Lifesciences 48.30 Bn 44.63 Bn 1.29 Bn -
6 GE HealthCare Technologies 28.33 Bn 26.04 Bn 1.98 Bn 22.00 Mn
7 Dexcom 28.32 Bn 27.20 Bn 750.30 Mn -
8 Smith & Nephew 26.89 Bn 26.31 Bn - -
9 Koninklijke Philips 25.43 Bn 22.30 Bn 2.07 Bn -5.85 Mn
10 Axogen 2.11 Bn 2.01 Bn 46.19 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 90,000.00